Regeneus Ltd. | Balance Sheet

Fiscal year is July-June. All values AUD Thousands.
2014
2015
2016
2017
2018
Cash & Short Term Investments
2,785.30
3,381.60
581.50
4,135.10
1,091.60
Total Accounts Receivable
3,960.60
3,575.90
2,858.30
3,994.10
3,123.30
Inventories
205.70
99.00
30.10
21.90
15.30
Other Current Assets
137.70
72.00
32.80
109.80
82.80
Total Current Assets
7,089.30
7,128.40
3,502.70
8,260.90
4,313.00
Net Property, Plant & Equipment
1,361.50
891.90
801.60
610.10
417.20
Total Investments and Advances
542.60
210.00
210.00
78.00
41.30
Long-Term Note Receivable
-
1,322.00
1,409.30
-
-
Intangible Assets
30.00
26.10
11.30
5.80
1.60
Other Assets
1,235.60
0.90
-
210.00
210.00
Total Assets
10,259.10
9,579.30
5,934.80
9,164.80
4,983.10
ST Debt & Current Portion LT Debt
488.90
253.40
-
-
-
Accounts Payable
434.80
453.30
539.40
350.30
372.20
Other Current Liabilities
773.90
552.80
466.20
525.90
1,446.50
Total Current Liabilities
1,697.70
1,259.50
1,005.60
876.20
1,818.60
Long-Term Debt
253.40
-
-
-
-
Provision for Risks & Charges
-
47.60
144.50
188.70
242.80
Total Liabilities
1,951.00
1,307.10
1,150.10
1,064.90
2,061.40
Common Equity (Total)
8,308.00
8,272.10
4,784.70
8,099.90
2,921.80
Total Shareholders' Equity
8,308.00
8,272.10
4,784.70
8,099.90
2,921.80
Total Equity
8,308.00
8,272.10
4,784.70
8,099.90
2,921.80
Liabilities & Shareholders' Equity
10,259.10
9,579.30
5,934.80
9,164.80
4,983.10

About Regeneus

View Profile
Address
25 Bridge Street
Pymble New South Wales (NSW) 2073
Australia
Employees -
Website http://www.regeneus.com.au
Updated 07/08/2019
Regeneus Ltd. is regenerative medicine company. It develops and commercializes innovative cell-based therapies to address unmet medical needs in human and veterinary health. The company was founded by Ben Herbert and Graham Vesey on August 14, 2007 and is headquartered in Pymble, Australia.